IL1R2 and neoplasm: Histopathological analysis showed that the tumor malignancy of Il1r2−/− mice after treatment was significantly reduced compared with the control group, which further indicated that IL-1R2 blocking combined with immune checkpoint inhibitor therapy can effectively slow tumor growth.